DexCom forward PE DXCM
Share price divided by analysts' consensus earnings for the next twelve months, since 2018.
- Today, Nov 3, 2026
- 30.0×
- 8-year median
- 101×
- Against its 8-year history
- 12th
- percentile: 0 is its lowest day, 100 its highest
- 8-year range
- 22.8× to 412×
- Peer median
- 17.7×
DexCom's forward PE is 30.0× as of Nov 3, 2026.
That is below its 8-year median of 101×, lower than on 88% of days in the last 8 years.
Over that time it ranged from 22.8× in May 2026 to 412× in Jan 2019.
The median for 9 medical device stocks of a similar size is 17.7×.
Forward PE over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 30.1× | 22.8× | 32.8× |
| 2025 | 28.1× | 22.9× | 48.6× |
| 2024 | 43.9× | 38.0× | 88.5× |
| 2023 | 81.6× | 53.4× | 117× |
| 2022 | 115× | 81.2× | 160× |
| 2021 | 173× | 134× | 208× |
| 2020 | 159× | 102× | 199× |
| 2019 | 117× | 101× | 412× |
| 2018 | 326× | 298× | 412× |
Against its peers
Companies in Medical - Devices nearest DexCom's size, closest first, today.
| Company | Forward PE |
|---|---|
| DXCMDexCom | 30.0× |
| GEHCGE HealthCare Technologies | 15.4× |
| EWEdwards Lifesciences | 30.1× |
| ZBHZimmer Biomet | n/m |
| BSXBoston Scientific | 13.4× |
| SYKStryker | 19.4× |
| MDTMedtronic | 16.5× |
| ABTAbbott Laboratories | 18.9× |
| LIVNLivaNova | n/m |
| ITGRInteger | n/m |
| Peer median | 17.7× |
Where DexCom ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on DexCom
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.